Status:
RECRUITING
Comparing the Effects of Manual Hyperinflation and Diaphragmatic Proprioceptive Neuromuscular Facilitation on Pulmonary Functions in Patients on Mechanical Ventilation
Lead Sponsor:
omar hasham mohamed
Conditions:
COPD Exacerbation Acute
Eligibility:
MALE
50-60 years
Phase:
NA
Brief Summary
the goal of this clinical trial is to compare between to important physiotherapy modalities applied on mechanically ventilated COPD patients the the main question the study aim to answer is which one ...
Detailed Description
In this study, the effects of diaphragmatic proprioceptive neuromuscular facilitation and manual hyperinflation on pulmonary functions in patients on mechanical ventilation will be compared. The foll...
Eligibility Criteria
Inclusion
- Patients will be included in the study if they have the following criteria:
- Sixty male mechanically ventilated patients. They will be ventilated on pressure support (PS) mode of MV with this setting (Positive end-expiratory pressure \[PEEP\]) less than 8 cm H2O, FiO2 0.4 or less, SpO2 higher than 90) due to AECOPD.
- Their Glasgow Coma Scale score will be ranged from 13 to 15.
- Their age between 50 and 60 years old.
- Their BMI will be ranged from 25 to 34.9 kg/m2.
- Moderate (GOLD 2) and severe (GOLD 3) stages of COPD according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) grading system for the severity of COPD.
Exclusion
- The patients will be excluded from this study if they have one of the following criteria:
- Fever above 38.3 °C. Unstable hemodynamics. Thoracic or abdominal surgery that preclude the use of PNF exercises. Chest trauma such as rib fracture, flail chest and thoracic vertebra fracture or chest burns.
- Peripheral and central nervous system diseases. Active lung infection like tuberculosis. Active bleeding as alveolar hemorrhage, hemoptysis. Spinal cord injuries involved the phrenic nerve. Severe cardiac complications due to COPD.
Key Trial Info
Start Date :
August 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06221033
Start Date
August 30 2023
End Date
April 1 2024
Last Update
January 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gamal Abdelnasser Hospital
Alexandria, Alexandria Governorate, Egypt, 4027